CAS: 1356331-63-9
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | 7-(2,3-Di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid REF: 3D-GEC33163CAS: 1356331-63-9 | Min. 95% | Prezzo su richiesta | Mar 14 Gen 25 |
 | QCC-374 REF: TM-T19660CAS: 1356331-63-9 | 98% | 1.386,00 €~2.349,00 € | Mar 21 Gen 25 |
![7-(2,3-Di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid](https://static.cymitquimica.com/products/3D/thumb/GEC33163.jpg)
7-(2,3-Di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid
CAS:1356331-63-9
7-(2,3-Di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid is a peptide that belongs to the class of activators. It is used …
Formula:
C28H33N3O2
Purezza:
Min. 95%
Peso molecolare:
443.6 g/mol
Ref: 3D-GEC33163
| 25mg | Prezzo su richiesta | ||
| 50mg | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Martedì 14 Gennaio 2025
QCC-374
CAS:1356331-63-9
QCC-374 is a prostanoid agonist. It potentially for the treatment of pulmonary arterial hypertension.
Formula:
C28H33N3O2
Purezza:
98%
Colore e forma:
Solid
Peso molecolare:
443.58
Ref: TM-T19660
| 25mg | 1.386,00 € | ||
| 50mg | 1.849,00 € | ||
| 100mg | 2.349,00 € |
Consegna stimata in Stati Uniti, il Martedì 21 Gennaio 2025
